Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with ... 7thSpace Interactive (press release) Methods: Thirty-one active RA patients from a clinical trial (IMPRESS) who were randomized equally into treatment with either rituximab + methotrexate or placebo + methotrexate had MRI of the dominant hand/wrist at baseline, 12 weeks and 24 weeks at 3 ... |
